Fusion Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Fusion Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2021 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending March 31, 2024 was $9.19M, a 17.3% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $9.19M -$1.93M -17.3% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $9.6M +$8.89M +1250% Dec 31, 2023 10-K 2024-03-20
Q3 2023 $9.81M +$9.02M +1149% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $10.9M +$10M +1144% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.1M +$10.2M +1046% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $711K -$205K -22.4% Dec 31, 2022 10-K 2023-03-16
Q3 2022 $785K -$217K -21.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $878K -$215K -19.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $970K -$210K -17.8% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $916K Dec 31, 2021 10-K 2022-03-17
Q3 2021 $1M Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.09M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $1.18M Mar 31, 2021 10-Q 2021-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.